BFM
TYRA icon

Boothbay Fund Management’s Tyra Biosciences TYRA Stock Holding History

Boothbay Fund Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.54M Sell
173,559
-99,715
-36% -$3.3M 0.07% 321
2026
Q1 		$10.5M Buy
273,274
+52,097
+24% +$1.69M 0.14% 124
2025
Q4 		$5.81M Buy
221,177
+34,507
+18% +$634K 0.09% 253
2025
Q3 		$2.61M Buy
+186,670
New +$2.13M 0.04% 506
2025
Q1 		– Sell
-17,560
Closed -$244K – 1799
2024
Q4 		$244K Buy
+17,560
New +$319K 0.01% 1139
2023
Q3 		– Sell
-10,174
Closed -$173K – 2090
2023
Q2 		$173K Buy
+10,174
New +$148K ﹤0.01% 1512

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Boothbay Fund Management's TYRA Position: Q2 2026 in Review

Boothbay Fund Management reduced its Tyra Biosciences (TYRA) stake by 36% in Q2 2026, selling an estimated $3.3M and leaving 173,559 shares worth $5.54M. The position accounts for 0.07% of the portfolio, ranked #321.

Boothbay Fund Management first reported a position in TYRA in Q2 2023 and has held it in 6 quarters since. The position peaked at $10.5M in Q1 2026. 169 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Boothbay Fund Management held 173,559 shares of Tyra Biosciences worth $5.54M as of Q2 2026.
  • Boothbay Fund Management sold 99,715 Tyra Biosciences shares in Q2 2026, an estimated $3.3M.
  • Tyra Biosciences made up 0.07% of Boothbay Fund Management's portfolio in Q2 2026, its #321 holding.
  • Boothbay Fund Management first reported a position in Tyra Biosciences in Q2 2023 and has held it in 6 quarters since.
  • Boothbay Fund Management's Tyra Biosciences position peaked at $10.5M in Q1 2026.
  • 169 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.